Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Can cleaning REACH further in reducing hospital infections?

Otter JA.

Lancet Infect Dis. 2019 Apr;19(4):345-347. doi: 10.1016/S1473-3099(18)30795-3. Epub 2019 Mar 8. No abstract available.

PMID:
30858013
2.

Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London.

Otter JA, Natale A, Batra R, Tosas Auguet O, Dyakova E, Goldenberg SD, Edgeworth JD.

Clin Microbiol Infect. 2019 Mar 6. pii: S1198-743X(19)30094-1. doi: 10.1016/j.cmi.2019.02.026. [Epub ahead of print]

PMID:
30849431
3.

Effectiveness of daily chlorhexidine bathing for reducing gram-negative infections: A meta-analysis.

Patel A, Parikh P, Dunn AN, Otter JA, Thota P, Fraser TG, Donskey CJ, Deshpande A.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):392-399. doi: 10.1017/ice.2019.20. Epub 2019 Feb 26.

PMID:
30803462
4.

Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK.

Ming DK, Otter JA, Ghani R, Brannigan ET, Boonyasiri A, Mookerjee S, Gilchrist M, Holmes AH, Davies F.

J Hosp Infect. 2019 May;102(1):95-97. doi: 10.1016/j.jhin.2019.01.023. Epub 2019 Feb 1. No abstract available.

PMID:
30716340
5.

Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus infections in Japan and England.

Mizuno S, Iwami M, Kunisawa S, Naylor N, Yamashita K, Kyratsis Y, Meads G, Otter JA, Holmes AH, Imanaka Y, Ahmad R.

J Hosp Infect. 2018 Nov;100(3):280-298. doi: 10.1016/j.jhin.2018.06.026. Epub 2018 Jul 7.

PMID:
30369423
6.

Tolerance of MRSA ST239-TW to chlorhexidine-based decolonization: Evidence for keratinocyte invasion as a mechanism of biocide evasion.

Marbach H, Vizcay-Barrena G, Memarzadeh K, Otter JA, Pathak S, Allaker RP, Harvey RD, Edgeworth JD.

J Infect. 2019 Feb;78(2):119-126. doi: 10.1016/j.jinf.2018.10.007. Epub 2018 Oct 24.

PMID:
30367885
7.

Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.

Knight GM, Dyakova E, Mookerjee S, Davies F, Brannigan ET, Otter JA, Holmes AH.

BMC Med. 2018 Aug 16;16(1):141. doi: 10.1186/s12916-018-1117-4.

8.

Planning to halve Gram-negative bloodstream infection: getting to grips with healthcare-associated Escherichia coli bloodstream infection sources.

Otter JA, Galletly TJ, Davies F, Hitchcock J, Gilchrist MJ, Dyakova E, Mookerjee S, Holmes AH, Brannigan ET.

J Hosp Infect. 2019 Feb;101(2):129-133. doi: 10.1016/j.jhin.2018.07.033. Epub 2018 Jul 27.

PMID:
30059746
9.

Beware biofilm! Dry biofilms containing bacterial pathogens on multiple healthcare surfaces; a multi-centre study.

Ledwoch K, Dancer SJ, Otter JA, Kerr K, Roposte D, Rushton L, Weiser R, Mahenthiralingam E, Muir DD, Maillard JY.

J Hosp Infect. 2018 Nov;100(3):e47-e56. doi: 10.1016/j.jhin.2018.06.028. Epub 2018 Jul 17.

PMID:
30026003
10.

Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.

Mookerjee S, Dyakova E, Davies F, Bamford K, Brannigan ET, Holmes A, Otter JA.

J Hosp Infect. 2018 Sep;100(1):15-20. doi: 10.1016/j.jhin.2018.05.024. Epub 2018 Jun 5.

PMID:
29883616
11.

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.

Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, Friedland JS, Hargreaves S.

Lancet Infect Dis. 2018 Jul;18(7):796-811. doi: 10.1016/S1473-3099(18)30219-6. Epub 2018 May 17.

12.

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.

Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR.

J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027. Review.

PMID:
29514274
13.

Frequent Undetected Ward-Based Methicillin-Resistant Staphylococcus aureus Transmission Linked to Patient Sharing Between Hospitals.

Tosas Auguet O, Stabler RA, Betley J, Preston MD, Dhaliwal M, Gaunt M, Ioannou A, Desai N, Karadag T, Batra R, Otter JA, Marbach H, Clark TG, Edgeworth JD.

Clin Infect Dis. 2018 Mar 5;66(6):840-848. doi: 10.1093/cid/cix901.

14.

Reducing the number of missed isolation days in a paediatric high-dependency unit using semi-permanent pods.

Keward J, Bradshaw P, Otter JA.

J Infect Prev. 2017 Mar;18(2):67-71. doi: 10.1177/1757177416687831. Epub 2017 Feb 2.

15.

Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London.

Otter JA, Doumith M, Davies F, Mookerjee S, Dyakova E, Gilchrist M, Brannigan ET, Bamford K, Galletly T, Donaldson H, Aanensen DM, Ellington MJ, Hill R, Turton JF, Hopkins KL, Woodford N, Holmes A.

Sci Rep. 2017 Oct 5;7(1):12711. doi: 10.1038/s41598-017-12637-4.

16.

What Makes a Tweet Fly? Analysis of Twitter Messaging at Four Infection Control Conferences.

Mitchell BG, Russo PL, Otter JA, Kiernan MA, Aveling L.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1271-1276. doi: 10.1017/ice.2017.170. Epub 2017 Aug 22.

PMID:
28826428
17.

Can Copper-Coated Surfaces Prevent Healthcare-Associated Infections?

Weber DJ, Otter JA, Rutala WA.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):772-776. doi: 10.1017/ice.2017.90. No abstract available.

PMID:
28628001
18.

Identification of a distinctive phenotype for endocarditis-associated clonal complex 22 MRSA isolates with reduced vancomycin susceptibility.

Marbach H, Boakes E, Lynham S, Ward M, Otter JA, Edgeworth JD.

J Med Microbiol. 2017 May;66(5):584-591. doi: 10.1099/jmm.0.000470. Epub 2017 May 15.

PMID:
28504620
19.

Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum β-lactamase Enterobacteriaceae.

Dyakova E, Bisnauthsing KN, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth JD, Goldenberg SD, Otter JA.

Clin Microbiol Infect. 2017 Aug;23(8):577.e1-577.e3. doi: 10.1016/j.cmi.2017.02.019. Epub 2017 Feb 24.

20.

Comparative analysis of phenol-soluble modulin production and Galleria mellonella killing by community-associated and healthcare-associated meticillin-resistant Staphylococcusaureus strains.

Boakes E, Marbach H, Lynham S, Ward M, Edgeworth JD, Otter JA.

J Med Microbiol. 2016 Dec;65(12):1429-1433. doi: 10.1099/jmm.0.000379. Epub 2016 Oct 26.

PMID:
27902400
21.

Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective.

Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, Parsons D, Brannigan ET, Robotham J, Holmes AH.

Clin Microbiol Infect. 2017 Mar;23(3):188-196. doi: 10.1016/j.cmi.2016.10.005. Epub 2016 Oct 13.

22.

Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.

Otter JA, Dyakova E, Bisnauthsing KN, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth JD, Goldenberg SD.

J Antimicrob Chemother. 2016 Dec;71(12):3556-3561. Epub 2016 Aug 11.

23.

Reduction in Clostridium difficile infection associated with the introduction of hydrogen peroxide vapour automated room disinfection.

McCord J, Prewitt M, Dyakova E, Mookerjee S, Otter JA.

J Hosp Infect. 2016 Oct;94(2):185-7. doi: 10.1016/j.jhin.2016.05.014. Epub 2016 May 31.

PMID:
27372150
24.

Interpreting the Joint Working Party Guidelines for cleaning up after carbapenemase-producing organisms: the devil's in the dilution.

Otter JA.

J Hosp Infect. 2016 Sep;94(1):108-9. doi: 10.1016/j.jhin.2016.06.006. Epub 2016 Jun 16. No abstract available.

PMID:
27368920
25.

Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network.

Vella V, Moore LS, Robotham JV, Davies F, Birgand GJ, Otter JA, Brannigan E, Dyakova E, Knight GM, Mookerjee S, Holmes AH.

J Hosp Infect. 2016 Oct;94(2):118-24. doi: 10.1016/j.jhin.2016.04.011. Epub 2016 Apr 22.

26.

Multidrug-resistant (MDR) Gram-negative bacteria information leaflets.

Brown C, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme W, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey P, Wilson AP.

J Hosp Infect. 2016 Jan;92(1):86-7. No abstract available.

PMID:
27158703
27.

Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London.

Hughes J, Goldenberg SD, Tosas O, Edgeworth JD, Otter JA.

J Infect Prev. 2016 May;17(3):130-134. doi: 10.1177/1757177415622693. Epub 2015 Dec 14.

28.

Evidence for Community Transmission of Community-Associated but Not Health-Care-Associated Methicillin-Resistant Staphylococcus Aureus Strains Linked to Social and Material Deprivation: Spatial Analysis of Cross-sectional Data.

Tosas Auguet O, Betley JR, Stabler RA, Patel A, Ioannou A, Marbach H, Hearn P, Aryee A, Goldenberg SD, Otter JA, Desai N, Karadag T, Grundy C, Gaunt MW, Cooper BS, Edgeworth JD, Kypraios T.

PLoS Med. 2016 Jan 26;13(1):e1001944. doi: 10.1371/journal.pmed.1001944. eCollection 2016 Jan.

29.

Reflections from Infection Prevention 2015: beating the bugs, improving the systems and thinking outside the box.

Otter JA.

J Infect Prev. 2016 Jan;17(1):37-41. doi: 10.1177/1757177415617244. Epub 2015 Nov 18. No abstract available.

31.

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party.

Wilson AP, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme W, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey P.

J Hosp Infect. 2016 Jan;92 Suppl 1:S1-44. doi: 10.1016/j.jhin.2015.08.007. Epub 2015 Nov 16. No abstract available.

PMID:
26598314
32.

Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination.

Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ.

J Hosp Infect. 2016 Mar;92(3):235-50. doi: 10.1016/j.jhin.2015.08.027. Epub 2015 Oct 3. Review.

PMID:
26597631
33.

Terminal decontamination of the Royal Free London's high-level isolation unit after a case of Ebola virus disease using hydrogen peroxide vapor.

Otter JA, Mepham S, Athan B, Mack D, Smith R, Jacobs M, Hopkins S.

Am J Infect Control. 2016 Feb;44(2):233-5. doi: 10.1016/j.ajic.2015.08.025.

PMID:
26521699
34.

A Successful Vancomycin-Resistant Enterococci Reduction Bundle at a Singapore Hospital.

Fisher D, Pang L, Salmon S, Lin RT, Teo C, Tambyah P, Jureen R, Cook AR, Otter JA.

Infect Control Hosp Epidemiol. 2016 Jan;37(1):107-9. doi: 10.1017/ice.2015.251. Epub 2015 Oct 21.

PMID:
26486456
35.

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries.

Otter JA, Mutters NT, Tacconelli E, Gikas A, Holmes AH.

Clin Microbiol Infect. 2015 Dec;21(12):1057-66. doi: 10.1016/j.cmi.2015.09.021. Epub 2015 Oct 3. Review.

36.

Biofilms mean that the 'environmentome' of hospital surfaces is teeming with life.

Otter JA.

J Hosp Infect. 2015 Nov;91(3):218-9. doi: 10.1016/j.jhin.2015.08.016. Epub 2015 Aug 28. No abstract available.

PMID:
26412396
37.

The inaugural Healthcare Infection Society Middle East Summit: 'No action today. No cure tomorrow.'.

Otter JA.

J Hosp Infect. 2015 Nov;91(3):199-201. doi: 10.1016/j.jhin.2015.06.021. Epub 2015 Aug 22. No abstract available.

PMID:
26364210
38.

Clonal variation in high- and low-level phenotypic and genotypic mupirocin resistance of MRSA isolates in south-east London.

Hughes J, Stabler R, Gaunt M, Karadag T, Desai N, Betley J, Ioannou A, Aryee A, Hearn P, Marbach H, Patel A, Otter JA, Edgeworth JD, Tosas Auguet O.

J Antimicrob Chemother. 2015 Dec;70(12):3191-9. doi: 10.1093/jac/dkv248. Epub 2015 Aug 27.

39.

Contamination of the Hospital Environment From Potential Clostridium difficile Excretors Without Active Infection.

Biswas JS, Patel A, Otter JA, van Kleef E, Goldenberg SD.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):975-7. doi: 10.1017/ice.2015.79. Epub 2015 Apr 10.

PMID:
25857829
40.

What's trending in the infection prevention and control literature? From HIS 2012 to HIS 2014, and beyond.

Otter JA.

J Hosp Infect. 2015 Apr;89(4):229-36. doi: 10.1016/j.jhin.2015.02.004. Epub 2015 Feb 21. Review.

PMID:
25774048
41.

Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.

Biswas JS, Patel A, Otter JA, Wade P, Newsholme W, van Kleef E, Goldenberg SD.

J Hosp Infect. 2015 Jul;90(3):267-70. doi: 10.1016/j.jhin.2015.01.015. Epub 2015 Feb 9.

42.

Evaluation of hydrogen peroxide vapor for the inactivation of nosocomial pathogens on porous and nonporous surfaces.

Lemmen S, Scheithauer S, Häfner H, Yezli S, Mohr M, Otter JA.

Am J Infect Control. 2015 Jan;43(1):82-5. doi: 10.1016/j.ajic.2014.10.007.

PMID:
25564129
43.

Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection.

Otter JA, Vickery K, Walker JT, deLancey Pulcini E, Stoodley P, Goldenberg SD, Salkeld JA, Chewins J, Yezli S, Edgeworth JD.

J Hosp Infect. 2015 Jan;89(1):16-27. doi: 10.1016/j.jhin.2014.09.008. Epub 2014 Oct 2. Review.

PMID:
25447198
44.

Surface contamination in operating rooms: a risk for transmission of pathogens?

Yezli S, Barbut F, Otter JA.

Surg Infect (Larchmt). 2014 Dec;15(6):694-9. doi: 10.1089/sur.2014.011. Review.

PMID:
25317716
45.

Journal roundup.

Otter JA.

J Hosp Infect. 2014 Sep;88(1):55-7. No abstract available.

PMID:
25271334
46.

Journal roundup.

Otter JA.

J Hosp Infect. 2014 Aug;87(4):249-50. No abstract available.

PMID:
25229104
47.

Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae.

Curran ET, Otter JA.

J Infect Prev. 2014 Sep;15(5):193-198. doi: 10.1177/1757177414546707. No abstract available.

48.

Implications of targeted versus universal admission screening for meticillin-resistant Staphylococcus aureus carriage in a London hospital.

Otter JA, Tosas-Auguet O, Herdman MT, Williams B, Tucker D, Edgeworth JD, French GL.

J Hosp Infect. 2014 Jul;87(3):171-4. doi: 10.1016/j.jhin.2014.04.005. Epub 2014 May 10.

PMID:
24928784
49.

Identification and control of a gentamicin resistant, meticillin susceptible Staphylococcus aureus outbreak on a neonatal unit.

Otter JA, Davies B, Menson E, Klein JL, Watts TL, Kearns AM, Pichon B, Edgeworth JD, French GL.

J Infect Prev. 2014 May;15(3):104-109. doi: 10.1177/1757177413520057. Epub 2014 Feb 11. Review.

50.

Aqueous oxygen peroxide treatment of VLUs in a primary care-based randomised, double-blind, placebo-controlled trial.

O'Halloran PD, Winter PK, Otter JA, Adams NM, Chewins J.

J Wound Care. 2014 Apr;23(4):176, 178, 180-1 passim.

PMID:
24762381

Supplemental Content

Loading ...
Support Center